Digital pathology
Aug 13, 2026
Leica Biosystems Expands Digital Pathology Portfolio with Multiple FDA Clearances; Bracco’s VueJect Ultrasound Contrast Delivery System Gains FDA and Health Canada Authorizations; Oticon Introduces Next-Generation Reveal Hearing Aid With AI; Zepto Life Technology Secures Up to $8.9 Million NIAID Award for Infectious Disease Liquid Biopsy Platform; Nitinotes Broadens EASE IDE Trial Network for EndoZip; FastWave Medical Secures FDA IDE Approval for Pivotal Artero Peripheral IVL Trial
Leica Biosystems Expanded Digital Pathology Portfolio with Multiple FDA Clearances On 11 August 2026, Leica Biosystems announced that it had received multiple U.S. FDA 510(k) clearances for its connected clinical digital pathology portfolio. The regulatory clearances strengthened the company's digital path...
Read More...
Sep 10, 2025
From Lab to Bedside: The Rise of AI-Enabled Digital Pathology
Pathology—the discipline of diagnosing disease through tissue analysis, has long depended on glass slides and microscopes. Today, digital pathology is undergoing a remarkable shift, as whole-slide imaging (WSI) and artificial intelligence (AI) come together to streamline lab workflows, accelerate diagnoses, and enh...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
